200 related articles for article (PubMed ID: 10930222)
1. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.
Meyer W; Jurowich C; Reichel M; Steinhäuser B; Wünsch PH; Gebhardt C
Surg Today; 2000; 30(7):582-7. PubMed ID: 10930222
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in the operative treatment of ductal pancreatic carcinoma.
Gebhardt C; Meyer W; Reichel M; Wünsch PH
Langenbecks Arch Surg; 2000 Jan; 385(1):14-20. PubMed ID: 10664114
[TBL] [Abstract][Full Text] [Related]
3. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
[TBL] [Abstract][Full Text] [Related]
5. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection.
Ozaki H; Hiraoka T; Mizumoto R; Matsuno S; Matsumoto Y; Nakayama T; Tsunoda T; Suzuki T; Monden M; Saitoh Y; Yamauchi H; Ogata Y
Surg Today; 1999; 29(1):16-22. PubMed ID: 9934826
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
Åkerberg D; Ansari D; Andersson R
World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
9. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications.
Lee SJ; Sung YN; Kim SJ; Shin S; Cho H; Hruban RH; Hong SM
Pancreatology; 2020 Oct; 20(7):1486-1494. PubMed ID: 32948429
[TBL] [Abstract][Full Text] [Related]
12. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
13. Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis.
Tannapfel A; Wittekind C; Hünefeld G
Int J Pancreatol; 1992 Oct; 12(2):145-52. PubMed ID: 1460329
[TBL] [Abstract][Full Text] [Related]
14. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.
Takai S; Satoi S; Toyokawa H; Yanagimoto H; Sugimoto N; Tsuji K; Araki H; Matsui Y; Imamura A; Kwon AH; Kamiyama Y
Pancreas; 2003 Apr; 26(3):243-9. PubMed ID: 12657950
[TBL] [Abstract][Full Text] [Related]
16. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma.
Fukuda S; Oussoultzoglou E; Bachellier P; Rosso E; Nakano H; Audet M; Jaeck D
Arch Surg; 2007 Feb; 142(2):172-9; discussion 180. PubMed ID: 17309969
[TBL] [Abstract][Full Text] [Related]
17. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
18. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after curative resection for pancreatic ductal adenocarcinoma--Surgical treatment.
Benassai G; Quarto G; Perrotta S; Furino E; Benassai GL; Amato B; Bianco T; De Palma G; Forestieri P
Int J Surg; 2015 Sep; 21 Suppl 1():S1-3. PubMed ID: 26118618
[TBL] [Abstract][Full Text] [Related]
20. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]